INDV

Indivior Pharmaceuticals Inc.

• NASDAQ·19h ago

  IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

• Simply Wall St·1d ago

  Could Indivior (INDV) Turn Correctional Staffing Efficiencies Into a Durable Competitive Edge?

• Reuters·2d ago

  Indivior to report Q1 financial results, host webcast update

• Dow Jones·2d ago

  Press Release: Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

• NASDAQ·4d ago

  Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

• Simply Wall St·04/04 01:25

  Assessing Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After New SUBLOCADE Cost Savings Evidence In Corrections Settings

• NASDAQ·04/02 14:00

  5 Small Drug Stocks to Buy as Sector Recovery Gains Strength

• Simply Wall St·04/02 09:24

  Did Potential Jail Staffing Efficiencies From SUBLOCADE® Just Shift Indivior Pharmaceuticals' (INDV) Investment Narrative?

• Reuters·03/31 22:12

  Indivior model shows monthly Sublocade cuts jail MOUD staffing time versus methadone, oral buprenorphine

• Simply Wall St·03/31 16:11

  New Model Puts Indivior’s SUBLOCADE Correctional Opportunity In Focus

• NASDAQ·03/31 09:22

  Zacks.com featured highlights include Indivior, Ciena and Ultra Clean

• Seeking Alpha·03/30 17:23

  Indivior: Still Attractive After FY25 Earnings Beat

• Simply Wall St·03/30 13:05

  Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge?

• Reuters·03/27 10:07

  Indivior announces annual shareholder meeting; FY2025 total net revenue rises to $1.2 billion

• Seeking Alpha·03/25 16:31

  Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B